8-K//Current report
Eloxx Pharmaceuticals, Inc. 8-K
Accession 0001104659-24-041148
CIK 0001035354operating
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:11 PM ET
Size
200.5 KB
Accession
0001104659-24-041148
Documents
- 8-Ktm248887d2_8k.htmPrimary
FORM 8-K
- EX-101.SCHelox-20240325.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABelox-20240325_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREelox-20240325_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-24-041148-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLtm248887d2_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001035354
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:11 PM ET
- Size
- 200.5 KB